...
首页> 外文期刊>Clinical and vaccine immunology: CVI >Evaluation of a Rapid Immunochromatographic ODK0501 Assay for Detecting Streptococcus pneumoniae Antigen in Sputum Samples from Patients with Lower Respiratory Tract Infection
【24h】

Evaluation of a Rapid Immunochromatographic ODK0501 Assay for Detecting Streptococcus pneumoniae Antigen in Sputum Samples from Patients with Lower Respiratory Tract Infection

机译:快速免疫层析ODK0501分析检测下呼吸道感染患者痰液样本中肺炎链球菌抗原的评估

获取原文
   

获取外文期刊封面封底 >>

       

摘要

A novel, rapid, and noninvasive test (ODK0501) to detect Streptococcus pneumoniae antigen was evaluated in a Japanese multicenter study. ODK0501 uses polyclonal antibodies to detect C polysaccharide of S. pneumoniae from sputum samples by an immunochromatographic assay. The utility of ODK0501 was evaluated for 161 adult patients with lower respiratory tract infection between March 2006 and March 2007. Bacterial culture and identification, real-time PCR, and ODK0501 assays were performed on sputum samples, and the Binax Now Streptococcus pneumoniae antigen test was performed using urine samples obtained from the same patients. The performances of all tests were compared based on the results of bacterial culture and identification. The sensitivity and specificity of ODK0501 were 89.1% (49/55 samples) and 95.3% (101/106 samples), respectively. We then compared the Binax Now Streptococcus pneumoniae antigen test with ODK0501 using samples from 142 patients. The sensitivities of ODK0501 and the Binax Now S. pneumoniae antigen test were 90.0% (45/50 samples) and 62.0% (31/50 samples), respectively (P = 0.002). The relative quantity of S. pneumoniae in expectorated sputum was calculated using real-time PCR and indicated that the possibility of false-positive results for ODK0501 due to indigenous S. pneumoniae was low. The positive and negative concordance rates of ODK0501 and Binax Now were 96.8% (30/31 samples) and 21.1% (4/19 samples), respectively. Binax Now was less capable of detecting S. pneumoniae antigen among patients with underlying chronic obstructive pulmonary disease. In conclusion, ODK0501 is noninvasive, rapid, and an accurate tool for diagnosing respiratory infection caused by S. pneumoniae.
机译:日本一项多中心研究评估了一种新颖,快速,无创的​​检测肺炎链球菌抗原的方法(ODK0501)。 ODK0501使用多克隆抗体来检测 S的C多糖。免疫层析法检测痰标本中的肺炎。在2006年3月至2007年3月之间,对161名成年下呼吸道感染患者进行了ODK0501实用性评估。对痰液样本和Binax Now 肺炎链球菌进行了细菌培养和鉴定,实时PCR和ODK0501测定。 抗原测试是使用从同一患者获得的尿液样本进行的。根据细菌培养和鉴定的结果比较所有测试的性能。 ODK0501的敏感性和特异性分别为89.1%(49/55个样品)和95.3%(101/106个样品)。然后,我们使用来自142例患者的样本,将Binax Now 肺炎链球菌抗原测试与ODK0501进行了比较。 ODK0501和Binax Now S的灵敏度。肺炎抗原测试分别为90.0%(45/50个样本)和62.0%(31/50个样本)( P = 0.002)。 S的相对数量。实时定量PCR计算了痰中痰中的肺炎,结果表明ODK0501可能因天然 S而出现假阳性结果。肺炎很低。 ODK0501和Binax Now的正和负一致性比率分别为96.8%(30/31样本)和21.1%(4/19样本)。 Binax Now无法检测到 S。潜在的慢性阻塞性肺疾病患者的肺炎抗原。总之,ODK0501是无创,快速且准确的工具,可用于诊断由 S引起的呼吸道感染。肺炎

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号